|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,630 JPY | +0.23% |
|
+0.80% | +10.97% |
| Apr. 08 | U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease | RE |
| Apr. 03 | Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March | MT |
March 18 (Reuters) - The U.S. Food and Drug Administration said on Monday it had approved UK-based Orchard Therapeutics' gene therapy for the treatment of children with a rare hereditary disease called metachromatic leukodystrophy (MLD). (Reporting by Mariam Sunny in Bengaluru; Editing by Sriraj Kalluvila)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,686 PTS | +0.86% | +0.34% | - | ||
| 2,630 JPY | +0.23% | +0.80% | 8.94B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +10.97% | 8.94B | |
| +5.31% | 70.44B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| -0.50% | 1.64B |
KYOWA KIRIN CO. LTD. 
